Composition comprising camptothecin or a comptothecin derivative and a platin derivative for the treatment of cancer
AssigneeAventis Pharma S.A.
InventorMarie-Christine Bissery
Life of this patent
Estimating the term…
Abstract
The present invention relates to therapeutic associations for the treatment of cancer, comprising an effective amount of a camptothecin, or a camptothecin derivative, with an effective amount of an alkylating agent such as a platin derivative, and methods of using such therapeutic associations.
Claims15
A therapeutic pharmaceutical composition, comprising an effective amount of camptothecin, or a camptothecin derivative, in combination with an effective amount of a platin derivative for the treatment of solid tumors.
A therapeutic pharmaceutical composition, comprising an effective amount of CPT-11, in combination with an effective amount of a platin derivative for the treatment of solid tumors
A synergistic therapeutic pharmaceutical composition, comprising an effective amount at least two agents, wherein at least one agent is CPT-11, in combination with an effective amount of at least one second agent, wherein said second agent is cisplatin, for the treatment of solid tumors.
A method of treating solid tumors, comprising administering orally an effective amount of camptothecin, or a camptothecin derivative, as a first agent, in combination with intravenous administration of an effective amount of a platin derivative as a second agent.
A method of therapeutic administration of an anti-solid tumor composition, comprising an effective amount of camptothecin, or a camptothecin derivative, in combination with an effective amount of a platin derivative for the treatment of solid tumors, wherein said administration of the effective amounts is separate or together, and is simultaneous, semi-simultaneous, or is spaced out over a period of time.
Dependencies are inferred from the claim text.